Leeza Osipenko

Dr. Leeza Osipenko is the founder and CEO of Consilium Scientific, a non-profit advancing integrity in healthcare and clinical research. She was the former director of NICE Scientific Advice. Her current activities focus on health technology assessment, clinical trial integrity, evidence-based health policy, and rare disease research.

Dr. Leeza Osipenko is the founder and CEO of Consilium Scientific, a non-profit advancing integrity in healthcare and clinical research. She holds a PhD in systems engineering from the Stevens Institute of Technology in Hoboken, NJ and has previously held academic and consulting roles at the University of Warwick Medical School, the London School of Economics, and in projects for other UK public-sector agencies. She was the former director of NICE Scientific Advice. Her current activities focus on health technology assessment, clinical trial integrity, evidence-based health policy, and rare disease research.

By this expert

Is That New Procedure Proven? MedTech Billing Codes and Evidence-Based Medicine

Article | Mar 2, 2026

Introduced by the AMA in 2001, Category III CPT codes aimed to streamline financial reporting. Instead they became entangled in a politically driven, zero-sum reimbursement game.